Aspira Women's Health Files 8-K for Equity Sale
Ticker: AWHL · Form: 8-K · Filed: Mar 11, 2025 · CIK: 926617
Sentiment: neutral
Topics: equity-sale, definitive-agreement
TL;DR
Aspira Women's Health selling more stock, filing shows.
AI Summary
On March 5, 2025, Aspira Women's Health Inc. entered into a material definitive agreement related to unregistered sales of equity securities. The company, formerly known as Vermillion, Inc., Ciphergen Biosystems Inc., and Abiotic Systems, is incorporated in Delaware and headquartered in Austin, Texas.
Why It Matters
This filing indicates a potential capital raise or issuance of new shares, which could impact the company's financial structure and shareholder equity.
Risk Assessment
Risk Level: medium — Filings related to unregistered equity sales can indicate financial needs or strategic shifts that may carry inherent risks for investors.
Key Players & Entities
- Aspira Women's Health Inc. (company) — Registrant
- Vermillion, Inc. (company) — Former Company Name
- Ciphergen Biosystems Inc (company) — Former Company Name
- Abiotic Systems (company) — Former Company Name
- March 5, 2025 (date) — Earliest Event Reported
FAQ
What type of material definitive agreement was entered into by Aspira Women's Health Inc. on March 5, 2025?
The filing indicates a material definitive agreement related to unregistered sales of equity securities.
What is the exact name of the registrant as specified in its charter?
The exact name of the registrant is Aspira Women's Health Inc.
In which state is Aspira Women's Health Inc. incorporated?
Aspira Women's Health Inc. is incorporated in Delaware.
What were some of the former names of Aspira Women's Health Inc.?
Some of the former names of Aspira Women's Health Inc. include Vermillion, Inc., Ciphergen Biosystems Inc, and Abiotic Systems.
What is the business address of Aspira Women's Health Inc.?
The business address is 12117 Bee Caves Road, Building Three, Suite 100, Austin, TX 78738.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 11, 2025 regarding Aspira Women's Health Inc. (AWHL).